新闻
2024-02-27
Dianthus Therapeutics Announces Initiation of Phase 2 MaGic Trial of DNTH103 In Generalized Myasthenia Gravis (gMG)
临床2期临床申请
2024-02-27
潜在最佳!勃林格殷格翰GLP-1R/GCGR激动剂MASH II期研究成功
临床结果临床成功
2024-02-27
葆元医药/信达生物新一代ROS1抑制剂拟纳入优先审评
优先审批突破性疗法申请上市引进/卖出
2024-02-27
首个!近六成患者缓解,阿斯利康单抗3期试验登上《新英格兰医学杂志》
临床结果临床3期
2024-02-27
靶向补体C3蛋白,圣因生物siRNA药物在新西兰获批1期临床!
siRNA临床申请核酸药物
2024-02-26
Celldex Therapeutics Presents Positive 12 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria
临床结果临床3期
2024-02-26
十余款1类新药获批临床
细胞疗法基因疗法申请上市临床申请免疫疗法
2024-02-26
传奇生物获得CHMP对CARVYKTI®用于前线治疗的积极意见
细胞疗法免疫疗法上市批准临床结果
2024-02-26
Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder
临床研究
2024-02-26
Biodexa Announces Positive Top Line Phase I Clinical Trial Results for Diffuse Midline Glioma and Provides R&D Update
临床结果临床2期ASCO会议